You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API metformin hydrochloride extended-release


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing metformin hydrochloride extended-release

Company Ingredient NDC Excipient
Apotex Corp metformin hydrochloride extended-release 60505-4701 ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Apotex Corp metformin hydrochloride extended-release 60505-4701 CARBOMER HOMOPOLYMER TYPE A
Apotex Corp metformin hydrochloride extended-release 60505-4701 CARBOMER HOMOPOLYMER TYPE B
Apotex Corp metformin hydrochloride extended-release 60505-4701 DIBUTYL SEBACATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for metformin hydrochloride extended-release

Excipient focus: ACETONE

Excipient focus: AMMONIO METHACRYLATE COPOLYMER TYPE A

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

metformin hydrochloride extended-release drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Company Ingredient NDC
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-445
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-503
Qingdao BAHEAL Pharmaceutical Co Ltd metformin hydrochloride extended-release tablets 70247-018
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: CARBOMER HOMOPOLYMER TYPE A

metformin hydrochloride extended-release drug variants not containing CARBOMER HOMOPOLYMER TYPE A

Company Ingredient NDC
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-445
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-503
Qingdao BAHEAL Pharmaceutical Co Ltd metformin hydrochloride extended-release tablets 70247-018
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: CARBOMER HOMOPOLYMER TYPE B

metformin hydrochloride extended-release drug variants not containing CARBOMER HOMOPOLYMER TYPE B

Company Ingredient NDC
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-445
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-503
Qingdao BAHEAL Pharmaceutical Co Ltd metformin hydrochloride extended-release tablets 70247-018
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: CELLULOSE ACETATE

Excipient focus: COPOVIDONE K25-31

metformin hydrochloride extended-release drug variants not containing COPOVIDONE K25-31

Company Ingredient NDC
Apotex Corp metformin hydrochloride extended-release 60505-4701
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-445
Qingdao BAHEAL Pharmaceutical Co Ltd metformin hydrochloride extended-release tablets 70247-018
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: CROSPOVIDONE

metformin hydrochloride extended-release drug variants not containing CROSPOVIDONE

Company Ingredient NDC
Apotex Corp metformin hydrochloride extended-release 60505-4701
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-503
Qingdao BAHEAL Pharmaceutical Co Ltd metformin hydrochloride extended-release tablets 70247-018
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: DIBUTYL SEBACATE

metformin hydrochloride extended-release drug variants not containing DIBUTYL SEBACATE

Company Ingredient NDC
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-445
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-503
Qingdao BAHEAL Pharmaceutical Co Ltd metformin hydrochloride extended-release tablets 70247-018
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: ETHYLCELLULOSE

metformin hydrochloride extended-release drug variants not containing ETHYLCELLULOSE

Company Ingredient NDC
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-445
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-503
Qingdao BAHEAL Pharmaceutical Co Ltd metformin hydrochloride extended-release tablets 70247-018
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

metformin hydrochloride extended-release drug variants not containing HYPROMELLOSE 2208

Company Ingredient NDC
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-445
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-503
Qingdao BAHEAL Pharmaceutical Co Ltd metformin hydrochloride extended-release tablets 70247-018
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: HYPROMELLOSE 2910

metformin hydrochloride extended-release drug variants not containing HYPROMELLOSE 2910

Company Ingredient NDC
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-445
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-503
Qingdao BAHEAL Pharmaceutical Co Ltd metformin hydrochloride extended-release tablets 70247-018
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: HYPROMELLOSES

Excipient focus: MAGNESIUM STEARATE

metformin hydrochloride extended-release drug variants containing MAGNESIUM STEARATE

Company Ingredient NDC
Apotex Corp metformin hydrochloride extended-release 60505-4701
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-445
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-503
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

metformin hydrochloride extended-release drug variants containing TITANIUM DIOXIDE

Company Ingredient NDC
AiPing Pharmaceutical Inc metformin hydrochloride extended-release tablets 11788-037
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-445
ScieGen Pharmaceuticals Inc metformin hydrochloride extended-release tablets 50228-503
Qingdao BAHEAL Pharmaceutical Co Ltd metformin hydrochloride extended-release tablets 70247-018
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group